BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8351518)

  • 1. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.
    Liu P; Tarlé SA; Hajra A; Claxton DF; Marlton P; Freedman M; Siciliano MJ; Collins FS
    Science; 1993 Aug; 261(5124):1041-4. PubMed ID: 8351518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.
    Poirel H; Radford-Weiss I; Rack K; Troussard X; Veil A; Valensi F; Picard F; Guesnu M; Leboeuf D; Melle J
    Blood; 1995 Mar; 85(5):1313-22. PubMed ID: 7858261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
    Hajra A; Liu PP; Speck NA; Collins FS
    Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
    Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
    Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.
    Wijmenga C; Gregory PE; Hajra A; Schröck E; Ried T; Eils R; Liu PP; Collins FS
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1630-5. PubMed ID: 8643682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells.
    Hajra A; Liu PP; Wang Q; Kelley CA; Stacy T; Adelstein RS; Speck NA; Collins FS
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1926-30. PubMed ID: 7892201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.
    Marlton P; Claxton DF; Liu P; Estey EH; Beran M; LeBeau M; Testa JR; Collins FS; Rowley JD; Siciliano MJ
    Blood; 1995 Feb; 85(3):772-9. PubMed ID: 7833479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.
    Liu PP; Hajra A; Wijmenga C; Collins FS
    Blood; 1995 May; 85(9):2289-302. PubMed ID: 7727763
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
    Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
    Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16.
    Novak M; Laczika K; Mitterbauer M; Purtscher B; Scheidel-Petrovic A; Lechner K; Jaeger U; Haas OA
    Blood; 1995 Sep; 86(6):2449-50. PubMed ID: 7662994
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
    Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
    Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
    Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
    Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
    Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
    Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.
    van der Reijden BA; Lombardo M; Dauwerse HG; Giles RH; Mühlematter D; Bellomo MJ; Wessels HW; Beverstock GC; van Ommen GJ; Hagemeijer A
    Blood; 1995 Jul; 86(1):277-82. PubMed ID: 7795233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.
    Nuchprayoon I; Meyers S; Scott LM; Suzow J; Hiebert S; Friedman AD
    Mol Cell Biol; 1994 Aug; 14(8):5558-68. PubMed ID: 8035830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16.
    Kanto S; Chiba N; Tanaka Y; Fujita S; Endo M; Kamada N; Yoshikawa K; Fukuzaki A; Orikasa S; Watanabe T; Satake M
    Leukemia; 2000 Jul; 14(7):1253-9. PubMed ID: 10914550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
    Adya N; Stacy T; Speck NA; Liu PP
    Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo.
    Dauwerse JG; Wessels JW; Giles RH; Wiegant J; van der Reijden BA; Fugazza G; Jumelet EA; Smit E; Baas F; Raap AK
    Hum Mol Genet; 1993 Oct; 2(10):1527-34. PubMed ID: 8268905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
    Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
    Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.